Mitchell Smith - Dissemin

Language
Login

All papers authored by Mitchell Smith

Distributing this paper is prohibited by the publisher

2023 Efrat Luttwak

ORCID

, Mitchell R. Smith

ORCID

, Andrew D. Zelenetz

ORCID

Is there a pathway for phosphatidylinositol 3-kinase delta inhibitors to be approved therapeutics for B-cell lymphoma therapy

Upload

This paper was not found in any repository, but could be made available legally by the author.

2018 Mitchell R. Smith

ORCID

, Robert F. Weiss

Optimal use of novel agents in chronic lymphocytic leukemia

Upload

This paper was not found in any repository, but could be made available legally by the author.

2017 Peter Martin

ORCID

, Zhengming Chen, Bruce D. Cheson, Katherine S. Robinson, Cheson Bd, Richard H. van der Jagt, Saurabh A. Rajguru, Michael Williams, Jonathan W. Friedberg, Robinson Ks, Ann S. LaCasce, Rajguru Sa, Kristen N. Ganjoo, Friedberg Jw, Nancy L. Bartlett

ORCID

and 18 other authors

Long-term outcomes, secondary malignancies and stem cell collection following bendamustine in patients with previously treated non-Hodgkin lymphoma

Upload

Distributing this paper is prohibited by the publisher

2016 Nancy L. Bartlett

ORCID

, Mitchell R. Smith

ORCID

, Bartlett Nl, Tanya Siddiqi, Smith Mr, Ranjana H. Advani, Advani Rh, Owen A. O’Connor, Jeff P. Sharman, O'Connor Oa, Tatyana Feldman, Sharman Jp, Kerry J. Savage, Andrei R. Shustov, Savage Kj and 11 other authors

Brentuximab vedotin activity in diffuse large B-cell lymphoma with CD30 undetectable by visual assessment of conventional immunohistochemistry

Upload

This paper is made freely available by the publisher.

2015 Debasis Pore, J. Bodo, Avinash Danda, Di Yan, James G. Phillips, Neetu Gupta, Daniel Lindner, Brian T. Hill, MItchell R. Smith

ORCID

, Eric D. Hsi

Identification of Ezrin-Radixin-Moesin proteins as novel regulators of pathogenic B cell receptor signaling and tumor growth in diffuse large B cell lymphoma

Download from journals.aai.org

This paper is made freely available by the publisher.

G. S. Choudhary, S. Al-Harbi, S. Mazumder, B. T. Hill, M. R. Smith

ORCID

, J. Bodo, E. D. Hsi, A. Almasan

ORCID

MCL-1 and BCL-xL-dependent resistance to the BCL-2 inhibitor ABT-199 can be overcome by preventing PI3K/AKT/mTOR activation in lymphoid malignancies

Download from dx.doi.org

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

X. Zhao, S. Chen-Kiang, S. Shetty, M. Di Liberto, J. Bodo, L. Durkin, K. Eng, O. Elemento, M. R. Smith

ORCID

, E. D. Hsi

To the editor: CCMCL1: A new model of aggressive mantle cell lymphoma

Upload

This paper is made freely available by the publisher.

2014 Xiaoxian Zhao, Juraj Bodo, Danyu Sun, Lisa Durkin, Jeffrey Lin, Mitchell R. Smith

ORCID

, Eric D. Hsi

Combination of ibrutinib with ABT-199: synergistic effects on proliferation inhibition and apoptosis in mantle cell lymphoma cells through perturbation of BTK, AKT and BCL2 pathways

Download from onlinelibrary.wiley.com

This paper is made freely available by the publisher.

Anita Kumar, Kristie A. Blum, Henry C. Fung, Mitchell R. Smith

ORCID

, Paul A. Foster, Anas Younes

A phase 1 dose-escalation study of XmAb®2513 in patients with relapsed or refractory Hodgkin lymphoma

Download from onlinelibrary.wiley.com

This paper is made freely available by the publisher.

Arishya Sharma, Allison J. Janocha, Brian T. Hill, Mitchell R. Smith

ORCID

, Serpil C. Erzurum, Alexandru Almasan

ORCID

Targeting mTORC1-mediated Metabolic Addiction Overcomes Fludarabine Resistance in Malignant B Cells

Download from mcr.aacrjournals.org

This paper was not found in any repository, but could be made available legally by the author.

Kristen N. Ganjoo, Sven de Vos, Brad L. Pohlman, Ian W. Flinn

ORCID

, Andres Forero-Torres, Nathan H. Enas, Damien M. Cronier, Nam H. Dang, Kenneth A. Foon, Susan P. Carpenter, Christopher A. Slapak, Brian K. Link

ORCID

, Mitchell R. Smith

ORCID

, Markus Y. Mapara, James E. Wooldridge

Phase 1/2 Study of Ocaratuzumab, an Fc-Engineered Humanized Anti-CD20 Monoclonal Antibody, in Low-Affinity FcγRIIIa Patients with Previously Treated Follicular Lymphoma

Upload

This paper was not found in any repository, but could be made available legally by the author.

Amer M. Zeidan, Ju-Whei Lee, Thomas Prebet, Peter Greenberg, Zhuoxin Sun, Mark Juckett, Mitchell R. Smith

ORCID

, Elisabeth Paietta, Janice Gabrilove, Harry P. Erba, Rhett P. Katterling, Martin S. Tallman, Steven D. Gore

Platelet count doubling after the first cycle of azacitidine therapy predicts eventual response and survival in patients with myelodysplastic syndromes and oligoblastic acute myeloid leukaemia but does not add to prognostic utility of the revised IPSS

Upload

This paper is made freely available by the publisher.

Mitchell R. Smith

ORCID

Allogeneic Transplantation for Lymphoma: Risk-Benefit Balance Is in the Eye of the Beholder

Download from doi.org

This paper is made freely available by the publisher.

Angela M. B. Collie, Jörk Nölling, Kiran M. Divakar, Jeffrey J. Lin, Paula Carver, Lisa M. Durkin, Brian T. Hill, Mitchell R. Smith

ORCID

, Tomas Radivoyevitch, Lilly I. Kong, Thomas Daly, Gurunathan Murugesan, Jeanna Guenther-Johnson, Sandeep S. Dave, Elena A. Manilich and 1 other authors

Molecular subtype classification of formalin-fixed, paraffin-embedded diffuse large B-cell lymphoma samples on the ICEPlex®system

Download from onlinelibrary.wiley.com

This paper is made freely available by the publisher.

Andrew M. Evens

ORCID

, Mitchell R. Smith

ORCID

, Izidore S. Lossos, Irene Helenowski, Michael Millenson, Jane N. Winter, Steve T. Rosen, Leo I. Gordon

Frontline bortezomib and rituximab for the treatment of newly diagnosed high tumour burden indolent non-Hodgkin lymphoma: a multicentre phase II study

Download from onlinelibrary.wiley.com

This paper is available in a repository.

Thomas Prebet

ORCID

, Zhuoxin Sun, Maria E. Figueroa, Rhett Ketterling, Ari Melnick, Peter L. Greenberg, James Herman, Mark Juckett, Eunice S. Wang, Mitchell R. Smith

ORCID

, Lisa Malick, Elisabeth Paietta, Magdalena Czader, Mark Litzow, Janice Gabrilove and 3 other authors

Prolonged Administration of Azacitidine With or Without Entinostat for Myelodysplastic Syndrome and Acute Myeloid Leukemia With Myelodysplasia-Related Changes: Results of the US Leukemia Intergroup Trial E1905

Download from www.ncbi.nlm.nih.gov

This paper is made freely available by the publisher.

Amer M. Zeidan, Ju-Whei Lee, Thomas Prebet

ORCID

, Peter Greenberg, Zhuoxin Sun, Mark Juckett, Mitchell R. Smith

ORCID

, Elisabeth Paietta, Janice Gabrilove, Harry P. Erba, Martin S. Tallman, Steven D. Gore

Comparison of the prognostic utility of the revised International Prognostic Scoring System and the French Prognostic Scoring System in azacitidine-treated patients with myelodysplastic syndromes

Download from onlinelibrary.wiley.com

This paper is made freely available by the publisher.

Julie E. Chang, Hailun Li, Mitchell R. Smith

ORCID

, Randy D. Gascoyne, Elisabeth M. Paietta, David T. Yang, Ranjana H. Advani, Sandra J. Horning, Brad S. Kahl

Phase 2 study of VcR-CVAD with maintenance rituximab for untreated mantle cell lymphoma: an Eastern Cooperative Oncology Group study (E1405)

Download from www.bloodjournal.org

This paper is made freely available by the publisher.

Mitchell R. Smith

ORCID

, Fang Jin, Indira Joshi

Milatuzumab and veltuzumab induce apoptosis through JNK signalling in an NF‐κB dependent human transformed follicular lymphoma cell line

Download from onlinelibrary.wiley.com

This paper was not found in any repository, but could be made available legally by the author.

2013 Mitchell R. Smith

ORCID

Is Early Hematopoietic Stem-Cell Transplantation Necessary in Mantle-Cell Lymphoma?

Upload

Missing publications? Search for publications with a matching author name.